The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Roche Acquires Trophos for €120m plus €350m Milestones (2015-01-16)
> Results from pivotal Phase II study suggest potential of olesoxime for treatment of patients with spinal muscular atrophy (SMA) > US and EU regulatory authorities have granted orphan drug designation to olesoxime Roche (SIX: RO, ROG; OTCQX: RHHBY) announc...
- Boehringer: Biological Manufacturing Services for Sanofi (2015-01-15)
Boehringer Ingelheim and Sanofi announced today that they enter into an alliance to extend Sanofi’s manufacturing capacity network for therapeutic monoclonal antibodies. Boehringer Ingelheim’s cell culture operations will provide contract manufacturing capacities t...
- New IMI Project to Prevent Alzheimer’s Dementia (2015-01-15)
> The European Prevention of Alzheimer’s dementia (EPAD) Initiative is a collaborative research initiative to improve the chance of successfully preventing Alzheimer’s dementia and to better understand early aspects of Alzheimer’s disease before dementia develops. ...
- Roche Licenses EGFR Pathway-related IP to Qiagen (2015-01-14)
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the company has entered into an agreement with QIAGEN that includes a provision of non-exclusive licenses to recently granted Roche patents pertaining to the detection of mutations in the EGFR pathway (includi...
- MDxHealth Licenses Epigenetic Technology to Oncgnostics (2015-01-14)
MDxHealth SA (Euronext: MDXH), a leading molecular diagnostics company in the field of personalized cancer treatment, today announced that it has granted a limited worldwide license for its patented methylation specific PCR (MSP) technology to oncgnostics GmbH in J...
- HLI to Perform Whole Genome Sequencing for Genentech (2015-01-14)
Human Longevity, Inc. (HLI), the human health information technology and health care company, today announced a multi-year agreement with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), to conduct whole genome sequencing of tens of thousands of...
- Boehringer, Vanderbilt University to Develop Ras Inhibitors (2015-01-14)
Boehringer Ingelheim announced today that it has established a research alliance with Vanderbilt University and the cancer drug discovery laboratory of Professor Stephen W. Fesik, Ph.D., the Orrin H. Ingram, II Chair in Cancer Research and Professor of Biochemistry...
- Roche, Meiji and Fedora to Develop New Antibiotic OP0595 (2015-01-13)
> Roche licenses investigational beta-lactamase inhibitor OP0595 > OP0595 targets beta-lactamase enzymes in combination with new or existing beta-lactam antibiotics to enhance their effectiveness in difficult-to-treat bacterial infections Roche (SIX: RO, ROG; O...
- Debiopharm Diagnostics Leads Investment Round in GenePOC (2015-01-13)
Debiopharm Diagnostics, part of Debiopharm Group™, is proud to be the lead investor in GenePOC, who are developing a highly innovative, low cost and quick MDx (Molecular Diagnostics) platform. Debiopharm Diagnostics led this investment round together with Emerillon...
- Boehringer, Yale Partner to Look for Immunotherapy Targets (2015-01-13)
Boehringer Ingelheim announced today a collaboration with Yale University, New Haven, Connecticut, USA, with the goal of researching novel therapeutic targets in the field of immune-modulation. Immune-modulation refers to a range of treatments aimed at harnessing a...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to email@example.com and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)